milrinone has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerhartz, B | 1 |
| Damodharan, S | 1 |
| Puccetti, DM | 1 |
| Boriosi, JP | 1 |
| Hokanson, JS | 1 |
| Capitini, CM | 1 |
1 other study available for milrinone and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Use of milrinone to support therapy-induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high-risk FLT3+ acute myeloid leukemia.
Topics: Child; fms-Like Tyrosine Kinase 3; Heart Failure; Hematopoietic Stem Cell Transplantation; Humans; L | 2023 |